IHL (ASX) Ann: Positive Results from IHL-675 (ARDS) animal study

Originally posted by MickeyMantle536: ↑

Read this if you’re new to IHL

I’m guessing some on this thread bought the news on Friday, watched the roller coaster price and are now wondering what this stock is all about.

There’s 4 clinical trials and a CBD oils business.

Each of the 4 clinical trials target a market that does not currently have a pharmaceutical treatment. Each market segment is also +$1 billion opportunity. This is not my opinion, it’s publicly stated by the Company.

ARDS is the leading cause of death in COVID patients and the first trial conducted by IHL. Stage 1 results from Friday were spectacular. Stage 2 starts now and results are due in less than 5 weeks. FDA drug development can be fast tracked due to COVID under what’s called Emergency Use Authorisation.

A genuine drug discovery in this space or any of the other 3 clinical areas will send this stock many multiples of the current price IMO.

The other 3 trials are Obstructive Sleep Apnoea, Traumatic Brain Injury and Temporomandibular Joint Disorder. More on that later.

If you want an example of what a CBD drug discovery looks like, research GW Pharma and Epidiolex. This is the first FDA approved CBD drug treating 2 rare forms of epilepsy. 2019 first year of sales, $296.4 million, first quarter 2020 sales were $116.1 million, so on track for $500 million this year. Market cap, $4 billion.

IHL has a strong cash balance, cash flow, a sub $50m EV and a proper medical advisory board.

Expand

Well said MM we are on our way and it is an exciting time and all that you suggest indicates that the stock is great value here and should imo be in double digits . It is IMO clearly undervalued based on fundamentals here . The market will twig soon as it becomes aware of the positive results and the potential of the ards trials . We have an excellent BOD and they will ensure the significance of the outcome of the results are marketed through the right channels .

I am comfortable here as disappointing as it is to see a sell for no fundamental reason . Anyway good riddance to the seller . We move on to bigger and better things with the newsflow that is coming .